A detailed history of Accel Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Accel Wealth Management holds 8,148 shares of PFE stock, worth $213,803. This represents 0.09% of its overall portfolio holdings.

Number of Shares
8,148
Previous 8,317 2.03%
Holding current value
$213,803
Previous $232,000 1.29%
% of portfolio
0.09%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$27.7 - $31.39 $4,681 - $5,304
-169 Reduced 2.03%
8,148 $235,000
Q2 2024

Jul 12, 2024

BUY
$25.26 - $29.6 $23,542 - $27,587
932 Added 12.62%
8,317 $232,000
Q1 2024

Apr 19, 2024

BUY
$25.89 - $29.73 $191,197 - $219,556
7,385 New
7,385 $204,000
Q2 2023

Jul 24, 2023

SELL
$36.12 - $41.79 $13,328 - $15,420
-369 Reduced 5.86%
5,931 $217,000
Q1 2023

Apr 20, 2023

SELL
$39.39 - $51.28 $9,414 - $12,255
-239 Reduced 3.65%
6,300 $257,000
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $21,292 - $27,795
510 Added 8.46%
6,539 $0
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $1,531 - $1,869
35 Added 0.58%
6,029 $268,000
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $1,442 - $1,710
31 Added 0.52%
5,994 $310,000
Q1 2022

Apr 29, 2022

BUY
$45.75 - $56.69 $11,803 - $14,626
258 Added 4.52%
5,963 $308,000
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $42,848 - $63,516
-1,037 Reduced 15.38%
5,705 $337,000
Q3 2021

Nov 04, 2021

SELL
$39.25 - $50.42 $2,394 - $3,075
-61 Reduced 0.9%
6,742 $290,000
Q2 2021

Aug 03, 2021

SELL
$35.91 - $40.68 $41,368 - $46,863
-1,152 Reduced 14.48%
6,803 $266,000
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $4,320 - $4,872
-129 Reduced 1.6%
7,955 $288,000
Q4 2020

Jan 27, 2021

BUY
$33.47 - $42.56 $270,571 - $344,055
8,084 New
8,084 $298,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Accel Wealth Management Portfolio

Follow Accel Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Accel Wealth Management with notifications on news.